Changes to the website
Sponsored By
Tocagen Clinical Trial
Please Click On The Above Banner For More Details
Braintumor Website

This is a list of chages to the website.

You can Subscribe to our RSS FEED: Subscribe to our RSS feed, which delivers brain tumor news and additions to the website via RSS.
(Click HERE for details on RSS.)

Displaying items 1 to 25 of about 4706

Next 25
Website Changes
11/25/2015 The Musella Foundation announced that it has awarded a $50,000 brain tumor research grant to Ninh Doan, MD, PhD, of the Medical College of Wisconsin.
11/23/2015 Combination of bevacizumab and lomustine with first recurrence of glioblastoma prolongs PFS but not OS
11/23/2015 Tocagen Presents Interim Data from Studies Evaluating Toca 511 & Toca FC at the Annual Meeting of the Society for Neuro-Oncology (SNO)
11/22/2015 Groundbreaking Global Brain Cancer Trial Planned
11/21/2015 ReACT: Long-term survival from a randomized phase II study of rindopepimut (CDX-110) plus bevacizumab in relapsed glioblastoma
11/21/2015 Phase I/II Study of Dianhydrogalactitol (Val-083) in Patients with Recurrent Malignant Glioma
11/20/2015 Celldex vaccine improves long-term brain cancer survival in study
11/20/2015 New Phase 3 Data show Optune in Combination with Second Line Chemotherapy is Superior to Second Line Chemotherapy Alone in Glioblastoma Patients at First Recurrence
11/20/2015 ImmunoCellular Therapeutics Ltd Presents Updated ICT-107 Phase 2 Survival and Immune Response Data at the Society for Neuro-Oncology Annual Meeting 2015
11/18/2015 CURE Media Group’s Heroes of Glioblastoma Announced Today
11/18/2015 IBTA E-News
11/17/2015 Global brain cancer trial aims to rapidly respond to new treatments
11/17/2015 Drug That Could Limit Spread of Deadly Brain Tumours
11/17/2015 Novocure Announces 18 Presentations on Tumor Treating Fields at SNO 2015 Including New Analyses of the EF-14 Newly Diagnosed Glioblastoma Clinical Trial Data
11/07/2015 Erlotinib augmentation with dapsone for rash mitigation and increased anti-cancer effectiveness.
11/07/2015 Toca5: A Phase 2/3 Randomized, Open Label Study of Toca 511™, a Retroviral Replicating Vector, Combined With Toca FC™ versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma
11/06/2015 Targeted treatment produces rapid shrinkage of recurrent, BRAF-mutant brain tumor
11/04/2015 No Impact With Mifepristone in Patients With Meningioma
10/30/2015 IBTA News
10/30/2015 Swedish Medical Center in Seattle announces a clinical trial in humans for the treatment of glioblastoma
10/30/2015 Does Early Postsurgical Temozolomide Plus Concomitant Radiochemotherapy Regimen Have Any Benefit in Newly-diagnosed Glioblastoma Patients? A Multi-center, Randomized, Parallel, Open-label, Phase II Clinical Trial.
10/14/2015 Cancer drug’s effectiveness overinflated in animal studies
10/14/2015 Dr. Jim Olson: How to defeat cancer, with help from nature, scorpions and innovative thinking
10/14/2015 Santosh Kesari, M.D., Ph.D., F.A.N.A, F.A.A.N., has joined the Pacific Brain Tumor Center and the John Wayne Cancer Institute at Providence Saint John’s Health Center in Santa Monica,
10/13/2015 Video Games Can Improve Cancer Survivors’ Cognitive Abilities

Home | Brain Tumor Guide | Search | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure NovoTTF-100A | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us | Doctors Address Book

Copyright (c) 1993 - 2015 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557

Website Design By
World Wide Websites